| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EXELExelixis, Inc. | 11.81B | 44.06 | 15.85 | 6.98% | 29.63% | 31.37% | 7.49% | 0.08 |
| INCYIncyte Corporation | 20.1B | 101.27 | 15.80 | 21.22% | 25.03% | 24.9% | 6.74% | 0.01 |
| GMABGenmab A/S | 18.13B | 29.44 | 15.36 | 30.67% | 46.8% | 114.25% | 6.6% | 0.03 |
| SNDXSyndax Pharmaceuticals, Inc. | 1.89B | 21.71 | -5.82 | -279.31% | -269.93% | 1.20 | ||
| RCUSArcus Biosciences, Inc. | 2.55B | 20.37 | -6.19 | -4.26% | -142.91% | -55.94% | 0.16 | |
| RLAYRelay Therapeutics, Inc. | 1.78B | 10.26 | -6.37 | 53.44% | -18.01% | -48.76% | 0.06 | |
| STROSutro Biopharma, Inc. | 1.74B | 20.47 | -6.92 | -59.64% | -205.18% | -234.19% | 4.57 | |
| OLMAOlema Pharmaceuticals, Inc. | 1.66B | 24.20 | -11 | -48.77% | 0.00 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 59.73M | 51.74M | 38.42M | 42.74M | 42.72M | 61.88M | 67.77M | 153.73M | 62.04M |
| Revenue Growth % | - | -13.38% | -25.75% | 11.24% | -0.03% | 44.84% | 9.52% | 126.84% | -59.64% |
| Cost of Goods Sold | 43.55M | 51.9M | 54.26M | 0 | 76.96M | 9.77M | 8.29M | 6.82M | 7.22M |
| COGS % of Revenue | 72.91% | 100.3% | 141.24% | - | 180.14% | 15.79% | 12.23% | 4.43% | 11.63% |
| Gross Profit | 16.18M | -156K | -15.84M | 42.74M | -34.24M | 52.11M | 59.48M | 146.91M | 54.83M |
| Gross Margin % | 27.09% | -0.3% | -41.24% | 100% | -80.14% | 84.21% | 87.77% | 95.57% | 88.37% |
| Gross Profit Growth % | - | -100.96% | -10055.77% | 369.75% | -180.12% | 252.19% | 14.16% | 146.98% | -62.68% |
| Operating Expenses | 58.37M | 71.01M | 75.64M | 98.2M | 36.82M | 150.63M | 188.43M | 236.19M | 293.28M |
| OpEx % of Revenue | 97.72% | 137.25% | 196.89% | 229.79% | 86.18% | 243.42% | 278.03% | 153.64% | 472.7% |
| Selling, General & Admin | 14.82M | 16.37M | 21.38M | 32.59M | 36.82M | 56M | 59.54M | 62.58M | 48.45M |
| SG&A % of Revenue | 24.81% | 31.65% | 55.65% | 76.26% | 86.18% | 90.5% | 87.86% | 40.71% | 78.1% |
| Research & Development | 43.55M | 54.64M | 54.26M | 65.61M | 76.96M | 104.4M | 137.17M | 180.43M | 252.04M |
| R&D % of Revenue | 72.91% | 105.6% | 141.24% | 153.53% | 180.14% | 168.71% | 202.4% | 117.36% | 406.24% |
| Other Operating Expenses | 87K | -77K | 1.91M | 0 | -76.96M | -9.77M | -8.29M | -6.82M | -7.22M |
| Operating Income | 1.36M | -19.27M | -37.22M | -55.47M | -71.06M | -98.52M | -128.94M | -89.28M | -238.45M |
| Operating Margin % | 2.28% | -37.25% | -96.89% | -129.79% | -166.32% | -159.22% | -190.26% | -58.07% | -384.34% |
| Operating Income Growth % | - | -1512.9% | -93.15% | -49.02% | -28.1% | -38.65% | -30.87% | 30.76% | -167.09% |
| EBITDA | 7.03M | -14.28M | -32.68M | -50.69M | -66.76M | -93.68M | -120.66M | -82.46M | -231.24M |
| EBITDA Margin % | 11.76% | -27.6% | -85.07% | -118.61% | -156.27% | -151.39% | -178.03% | -53.64% | -372.7% |
| EBITDA Growth % | - | -303.27% | -128.85% | -55.09% | -31.7% | -40.32% | -28.79% | 31.65% | -180.41% |
| D&A (Non-Cash Add-back) | 5.66M | 4.99M | 4.54M | 4.78M | 4.3M | 4.84M | 8.29M | 6.82M | 7.22M |
| EBIT | 1.36M | -19.08M | -37.22M | -51.39M | -28.05M | -102.4M | -113.36M | -74.73M | -187.67M |
| Net Interest Income | 251K | -416K | 16K | -276K | -2.47M | -2.56M | 109K | -9.24M | 13.36M |
| Interest Income | 251K | 273K | 1.62M | 4.07M | 1.51M | 577K | 3.46M | 14.51M | 44.42M |
| Interest Expense | 0 | 689K | 1.6M | 4.35M | 3.97M | 3.14M | 3.35M | 23.75M | 31.07M |
| Other Income/Expense | 338K | -416K | 1.91M | -276K | 38.93M | -7.01M | 12.24M | 677K | 13.36M |
| Pretax Income | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -116.7M | -88.6M | -225.1M |
| Pretax Margin % | 2.85% | -38.05% | -91.93% | -130.44% | -75.2% | -170.55% | -172.2% | -57.63% | -362.81% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 2.5M | 18.19M | 2.36M |
| Effective Tax Rate % | 100% | 100% | 100% | 100% | 100% | 100% | 102.14% | 120.53% | 101.05% |
| Net Income | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -119.2M | -106.79M | -227.46M |
| Net Margin % | 2.85% | -38.05% | -91.93% | -130.44% | -75.2% | -170.55% | -175.89% | -69.47% | -366.62% |
| Net Income Growth % | - | -1256.76% | -79.38% | -57.84% | 42.37% | -228.49% | -12.95% | 10.41% | -112.99% |
| Net Income (Continuing) | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -119.2M | -106.79M | -227.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 3.86 | -2.81 | -1.54 | -2.43 | -0.99 | -2.29 | -2.35 | -1.78 | -2.96 |
| EPS Growth % | - | -172.8% | 45.2% | -57.79% | 59.26% | -131.31% | -2.62% | 24.26% | -66.29% |
| EPS (Basic) | 3.86 | -2.81 | -1.55 | -2.43 | -0.99 | -2.29 | -2.35 | -1.78 | -2.96 |
| Diluted Shares Outstanding | 441.2K | 7M | 22.87M | 22.96M | 32.57M | 46.12M | 50.74M | 60.16M | 76.83M |
| Basic Shares Outstanding | 441.2K | 7M | 22.86M | 22.96M | 32.57M | 46.12M | 50.74M | 60.16M | 76.83M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 49.69M | 25.63M | 209.95M | 128.57M | 378.18M | 218.51M | 353.15M | 421.54M | 343.31M |
| Cash & Short-Term Investments | 47.52M | 22.02M | 204.49M | 117.86M | 368.14M | 197.94M | 334.36M | 375.62M | 316.89M |
| Cash Only | 11.59M | 22.02M | 125.3M | 4.96M | 206.15M | 30.41M | 47.25M | 69.27M | 190.3M |
| Short-Term Investments | 35.93M | 0 | 79.19M | 112.9M | 161.99M | 167.52M | 287.11M | 306.35M | 126.59M |
| Accounts Receivable | 577K | 1.62M | 2.49M | 6.3M | 5.56M | 12.45M | 7.12M | 36.08M | 8.62M |
| Days Sales Outstanding | 3.53 | 11.46 | 23.65 | 53.79 | 47.49 | 73.46 | 38.36 | 85.66 | 50.69 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 2.96M | 4.41M | 0 | 0 | 11.67M | 9.85M | 17.8M |
| Total Non-Current Assets | 19.59M | 15.14M | 13.19M | 27.8M | 15.93M | 122.89M | 53.79M | 49.19M | 43.9M |
| Property, Plant & Equipment | 18.69M | 14M | 10.93M | 9.63M | 12.94M | 51.59M | 51.06M | 44.76M | 35.87M |
| Fixed Asset Turnover | 3.20x | 3.70x | 3.51x | 4.44x | 3.30x | 1.20x | 1.33x | 3.43x | 1.73x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 482K | 223K | 15K | 15.62M | 0 | 68.78M | -32.02M | 0 | 0 |
| Other Non-Current Assets | 417K | 920K | 2.24M | 2.54M | 2.99M | 2.53M | 34.75M | 4.44M | 8.03M |
| Total Assets | 69.28M | 40.77M | 223.14M | 156.37M | 394.11M | 341.41M | 406.94M | 470.74M | 387.21M |
| Asset Turnover | 0.86x | 1.27x | 0.17x | 0.27x | 0.11x | 0.18x | 0.17x | 0.33x | 0.16x |
| Asset Growth % | - | -41.15% | 447.33% | -29.92% | 152.04% | -13.37% | 19.2% | 15.68% | -17.74% |
| Total Current Liabilities | 50.18M | 31.96M | 36.42M | 32.97M | 29.6M | 41.74M | 66.55M | 93.75M | 131.89M |
| Accounts Payable | 3.39M | 2.9M | 3.06M | 5.58M | 5.54M | 6.01M | 4.8M | 9.44M | 10.47M |
| Days Payables Outstanding | 28.45 | 20.41 | 20.59 | - | 26.29 | 224.42 | 211.26 | 505.52 | 529.7 |
| Short-Term Debt | 0 | 14.56M | 4.72M | 1M | 0 | 9.38M | 17.09M | 4.06M | 0 |
| Deferred Revenue (Current) | 43.58M | 10.71M | 21.57M | 19.46M | 14.6M | 5.5M | 16.76M | 20.67M | 69.78M |
| Other Current Liabilities | 22K | 143K | 7.06M | 901K | 627K | 11.42M | 11.64M | 18.58M | 16.91M |
| Current Ratio | 0.99x | 0.80x | 5.76x | 3.90x | 12.78x | 5.24x | 5.31x | 4.50x | 2.60x |
| Quick Ratio | 0.99x | 0.80x | 5.76x | 3.90x | 12.78x | 5.24x | 5.31x | 4.50x | 2.60x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 110M | 117.81M | 55.18M | 25.61M | 32.47M | 47.11M | 123.35M | 227.34M | 210.71M |
| Long-Term Debt | 0 | 0 | 10M | 8.88M | 24.55M | 15.74M | 3.77M | 0 | 180.81M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 31.22M | 29.57M | 23.15M | 15.67M |
| Deferred Tax Liabilities | -1.19M | 0 | 476K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 104.14M | 104.66M | 578K | 543K | 1.82M | 146K | 119K | 1.69M | 1.69M |
| Total Liabilities | 160.18M | 149.77M | 91.6M | 58.58M | 62.06M | 88.84M | 189.9M | 321.09M | 342.61M |
| Total Debt | 1.19M | 14.63M | 14.72M | 9.88M | 24.55M | 57.37M | 55.02M | 33.63M | 203.96M |
| Net Debt | -10.4M | -7.39M | -110.57M | 4.92M | -181.61M | 26.96M | 7.76M | -35.63M | 13.66M |
| Debt / Equity | - | - | 0.11x | 0.10x | 0.07x | 0.23x | 0.25x | 0.22x | 4.57x |
| Debt / EBITDA | 0.17x | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -1.48x | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -27.97x | -23.26x | -12.75x | -17.88x | -31.41x | -38.54x | -3.76x | -7.67x |
| Total Equity | -90.9M | -109M | 131.54M | 97.79M | 332.05M | 252.56M | 217.05M | 149.65M | 44.6M |
| Equity Growth % | - | -19.91% | 220.68% | -25.66% | 239.56% | -23.94% | -14.06% | -31.05% | -70.2% |
| Book Value per Share | -206.03 | -15.58 | 5.75 | 4.26 | 10.19 | 5.48 | 4.28 | 2.49 | 0.58 |
| Total Shareholders' Equity | -90.9M | -109M | 131.54M | 97.79M | 332.05M | 252.56M | 217.05M | 149.65M | 44.6M |
| Common Stock | 16K | 0 | 23K | 23K | 46K | 46K | 58K | 61K | 83K |
| Retained Earnings | -95.32M | -115.01M | -150.33M | -195.75M | -227.87M | -333.41M | -452.62M | -559.41M | -786.87M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -17K | -208K | -47K | 165K | 129K | -314K | -618K | 21K | 39K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -13.15M | -37.07M | 12.68M | -65.02M | -67.8M | -81.68M | 3.55M | -111.62M | -191.54M |
| Operating CF Margin % | -22.02% | -71.65% | 33.01% | -152.15% | -158.71% | -132% | 5.24% | -72.6% | -308.72% |
| Operating CF Growth % | - | -181.87% | 134.21% | -612.68% | -4.27% | -20.47% | 104.35% | -3245% | -71.61% |
| Net Income | 1.7M | -19.69M | -35.32M | -55.74M | -32.13M | -105.54M | -119.2M | -106.79M | -227.46M |
| Depreciation & Amortization | 5.66M | 4.99M | 4.54M | 4.78M | 4.3M | 4.84M | 5.69M | 6.82M | 7.22M |
| Stock-Based Compensation | 968K | 1.39M | 2.87M | 10.31M | 11.92M | 23.24M | 26.3M | 24.91M | 24.69M |
| Deferred Taxes | 80K | 3M | -1.5M | -1.3M | -41.01M | 7.24M | 0 | 0 | 0 |
| Other Non-Cash Items | 98K | 132K | -517K | 193K | 606K | 6.16M | -13.65M | -2.17M | -4.88M |
| Working Capital Changes | -21.66M | -26.9M | 42.61M | -23.26M | -11.49M | -17.62M | 104.41M | -34.38M | 8.9M |
| Change in Receivables | -171K | -1.05M | -865K | -3.81M | 739K | -6.89M | 5.34M | -28.96M | 27.46M |
| Change in Inventory | -389K | -354K | -1.67M | -1.25M | -58K | -4.54M | 0 | 0 | 0 |
| Change in Payables | 874K | -473K | 209K | 2.25M | -947K | 6.43M | -1.23M | 4.81M | 706K |
| Cash from Investing | 9.59M | 32.6M | -80.19M | -51.13M | 604K | -97.31M | -35.02M | -3.92M | 218.51M |
| Capital Expenditures | -4.39M | -3.32M | -1.56M | -3.48M | -7.13M | -15.32M | -7.86M | -4.32M | -3.1M |
| CapEx % of Revenue | 7.36% | 6.41% | 4.05% | 8.15% | 16.69% | 24.76% | 11.59% | 2.81% | 4.99% |
| Acquisitions | 16K | 0 | 0 | 47.65M | 0 | 0 | 28.74M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 16K | 80K | 80K | -47.65M | 89K | 9K | -28.73M | 0 | 0 |
| Cash from Financing | 177K | 14.64M | 170.78M | -4.18M | 269.25M | 3.26M | 48.31M | 137.55M | 94.05M |
| Debt Issued (Net) | 0 | 15M | 0 | -5M | 15M | 0 | -9.38M | -12.5M | -4.08M |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K | -994K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | -327K | 0 | -7K | 0 | 0 | 0 |
| Other Financing | 177K | -362K | 1.61M | -297K | 2.83M | 4.25M | 1.42M | 138.08M | 1.61M |
| Net Change in Cash | -3.38M | 10.17M | 103.28M | -120.34M | 202.05M | -175.74M | 16.84M | 22.01M | 121.02M |
| Free Cash Flow | -17.55M | -40.39M | 11.13M | -68.5M | -74.93M | -97M | -4.31M | -115.93M | -194.64M |
| FCF Margin % | -29.38% | -78.06% | 28.96% | -160.3% | -175.39% | -156.76% | -6.36% | -75.41% | -313.71% |
| FCF Growth % | - | -130.18% | 127.55% | -715.71% | -9.38% | -29.46% | 95.56% | -2590.44% | -67.89% |
| FCF per Share | -39.77 | -5.77 | 0.49 | -2.98 | -2.30 | -2.10 | -0.08 | -1.93 | -2.53 |
| FCF Conversion (FCF/Net Income) | -7.73x | 1.88x | -0.36x | 1.17x | 2.11x | 0.77x | -0.03x | 1.05x | 0.84x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 2.05M | 0 | 1.13M | 310K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 103K | 0 | 379K | 17.52M |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | -313.4% | -48.62% | -14.95% | -36.11% | -50.77% | -58.25% | -234.19% |
| Return on Invested Capital (ROIC) | - | - | - | -67.28% | -42.1% | -34.37% | -38.35% | -39.52% | -207.62% |
| Gross Margin | 27.09% | -0.3% | -41.24% | 100% | -80.14% | 84.21% | 87.77% | 95.57% | 88.37% |
| Net Margin | 2.85% | -38.05% | -91.93% | -130.44% | -75.2% | -170.55% | -175.89% | -69.47% | -366.62% |
| Debt / Equity | - | - | 0.11x | 0.10x | 0.07x | 0.23x | 0.25x | 0.22x | 4.57x |
| Interest Coverage | - | -27.97x | -23.26x | -12.75x | -17.88x | -31.41x | -38.54x | -3.76x | -7.67x |
| FCF Conversion | -7.73x | 1.88x | -0.36x | 1.17x | 2.11x | 0.77x | -0.03x | 1.05x | 0.84x |
| Revenue Growth | - | -13.38% | -25.75% | 11.24% | -0.03% | 44.84% | 9.52% | 126.84% | -59.64% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics